Teva Pharmaceutical Industries Limited (TEVA) Financial Statements (2024 and earlier)

Company Profile

Business Address 5 BAZEL ST
PETACH TIKVA, 49131
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,8012,1652,1771,9751,782963
Cash and cash equivalents2,8012,1652,1771,9751,782963
Restricted cash and investments      
Receivables3,6964,5294,5815,6765,8227,927
Inventory, net of allowances, customer advances and progress billings3,8333,8184,4034,4224,7314,924
Inventory3,8333,8184,4034,4224,7314,924
Prepaid expense1,1621,075945870899 
Disposal group, including discontinued operation10191898792 
Other current assets549965710434468 
Other undisclosed current assets  2   1,568
Total current assets:12,05112,57313,00513,46413,79415,382
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization    37
Operating lease, right-of-use asset419495559514
Property, plant and equipment5,7395,9826,2966,4366,8687,673
Intangible assets, net (including goodwill)23,90327,50629,54736,07838,92246,054
Goodwill17,63320,04020,62424,84624,91728,414
Intangible assets, net (excluding goodwill)6,2707,4668,92311,23214,00517,640
Deferred income tax assets1,453596695 
Other noncurrent assets441515538591731932
Deferred tax assets, net (2,703)
Other undisclosed noncurrent assets  (1) 3503683,277
Total noncurrent assets:31,95535,09337,63544,00646,88955,233
TOTAL ASSETS:44,00647,66650,64057,47060,68370,615
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,4532,2722,4411,7181,8532,069
Employee-related liabilities563685693870 
Accounts payable1,8871,6861,756   
Accrued liabilities56623    
Other undisclosed accounts payable and accrued liabilities    1,0259832,069
Debt2,1091,4263,1882,3452,2163,646
Disposal group, including discontinued operation 43    
Other liabilities1,005903933889804724
Other undisclosed current liabilities5,9026,3836,6028,7229,44911,482
Total current liabilities:11,46911,02713,16413,67414,32217,921
Noncurrent Liabilities
Long-term debt and lease obligation19,10322,03323,21024,99726,70028,829
Long-term debt, excluding current maturities19,10321,61722,73124,56226,70028,829
Liabilities, other than long-term debt4,1962,5782,2402,6403,8675,120
Deferred tax liabilities, net2,1403,277
Other liabilities3,8472,5782,2402,6401,7271,843
Operating lease, liability349416479435
Other undisclosed noncurrent liabilities5477849641,096  
Total noncurrent liabilities:23,84625,39526,41428,73330,56733,949
Other undisclosed liabilities   1   
Total liabilities:35,31536,42239,57942,40744,88951,870
Equity
Equity, attributable to parent, including:7,89710,27810,02613,97214,70717,359
Preferred stock      3,631
Common stock575757565654
Treasury stock, value(4,128)(4,128)(4,128)(4,128)(4,142)(4,149)
Additional paid in capital27,68827,56127,44327,31227,21023,479
Accumulated other comprehensive loss(2,838)(2,683)(2,399)(2,312)(2,459)(1,853)
Accumulated deficit(12,882)(10,529)(10,946)(6,956)(5,958)(3,803)
Other undisclosed equity, attributable to parent   (1)   
Equity, attributable to noncontrolling interest7949661,0351,0911,0871,386
Other undisclosed equity      
Total equity:8,69111,24411,06115,06315,79418,745
TOTAL LIABILITIES AND EQUITY:44,00647,66650,64057,47060,68370,615

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues14,92515,87816,65916,88718,85423,584
Revenue, net22,385
Cost of revenue
(Cost of Goods and Services Sold)
(7,952)(8,284)(8,933)(9,351)(10,558)(11,560)
Other undisclosed gross profit   1 (1,199)
Gross profit:6,9737,5947,7267,5378,29610,825
Operating expenses(3,445)(4,495)(4,668)(4,816)(4,147)(4,986)
Other operating income, net107984076  
Other undisclosed operating loss(5,734)(1,481)(6,670)(3,240)(5,786)(23,323)
Operating income (loss):(2,099)1,716(3,572)(443)(1,637)(17,484)
Nonoperating expense(966)(1,058)(834)(822)(959)(895)
Investment income, nonoperating 212160104413984
Interest and debt expense (930)(891)(963)(881)(920)(875)
Other undisclosed income from continuing operations before equity method investments, income taxes930891963881920875
Income (loss) from continuing operations before equity method investments, income taxes:(3,065)658(4,406)(1,265)(2,596)(18,379)
Income (loss) from equity method investments219138(13)(71)(3)
Income (loss) from continuing operations before income taxes:(3,044)667(4,268)(1,278)(2,667)(18,382)
Income tax expense (benefit)638(211)1682781951,933
Income (loss) from continuing operations:(2,406)456(4,100)(1,000)(2,472)(16,449)
Income (loss) before gain (loss) on sale of properties:456(4,100)(1,000)(2,472)(16,449)
Other undisclosed net income  1   
Net income (loss):(2,406)456(4,099)(1,000)(2,472)(16,449)
Net income (loss) attributable to noncontrolling interest53(39)1092322184
Other undisclosed net income (loss) attributable to parent   (1)  
Net income (loss) attributable to parent:(2,353)417(3,990)(999)(2,150)(16,265)
Preferred stock dividends and other adjustments     (249)(260)
Net income (loss) available to common stockholders, diluted:(2,353)417(3,990)(999)(2,399)(16,525)

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(2,406)456(4,099)(1,000)(2,472)(16,449)
Other comprehensive income (loss)(270)(391)(30)160(585)1,306
Other undisclosed comprehensive income      184
Comprehensive income (loss):(2,676)65(4,129)(840)(3,057)(14,959)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest1696853(12)296184
Other undisclosed comprehensive loss, net of tax, attributable to parent      (305)
Comprehensive income (loss), net of tax, attributable to parent:(2,507)133(4,076)(852)(2,761)(15,080)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: